You are here

  • Home
  • Archive
  • Volume 69, Issue 8
  • Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations

Article metrics

Article menu
Download PDFPDF
Original article
Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations

 

Online download statistics by month:

Online download statistics by month: January 2016 to March 2024

AbstractFullPdf
Jan 20162744162
Feb 2016621212
Mar 20164377
Apr 2016571614
May 20165354
Jun 20162337
Jul 2016268524
Aug 2016229437
Sep 2016112519
Oct 20168633
Nov 201613044
Dec 20165222
Jan 201781553
Feb 2017451015
Mar 20174593
Apr 20172972
May 201743138
Jun 20173821
Jul 20175451
Aug 201780102
Sep 20176422
Oct 20174853
Nov 20177800
Dec 20175622
Jan 20189032
Feb 20189052
Mar 201811295
Apr 20185530
May 20186432
Jun 20185310
Jul 20185151
Aug 20183731
Sep 20183141
Oct 20183700
Nov 20185533
Dec 20183512
Jan 20193533
Feb 20194011
Mar 20192865
Apr 20192823
May 20192711
Jun 20191300
Jul 20194043
Aug 20191311
Sep 20192512
Oct 20193533
Nov 20193222
Dec 20193700
Jan 20202822
Feb 20201400
Mar 20203421
Apr 20202512
May 20201810
Jun 20203800
Jul 20202010
Aug 2020500
Sep 20203000
Oct 20203100
Nov 20203821
Dec 20203302
Jan 20212600
Feb 20213503
Mar 20213530
Apr 20212111
May 2021900
Jun 2021222
Aug 2021110
Sep 2021332
Oct 20211100
Nov 20212910
Dec 20212700
Jan 20221511
Feb 20221600
Mar 20223522
Apr 20223150
May 20226900
Jun 20223930
Jul 20225202
Aug 20225630
Sep 20225511
Oct 202212555
Nov 20222221
Dec 20224010
Jan 20232721
Feb 20237221
Mar 20232631
Apr 20231232
May 20232200
Jun 2023200
Jul 20233410
Aug 20231111
Sep 20232300
Oct 20232910
Nov 20232512
Dec 20232410
Jan 202415511
Feb 20243311
Mar 20241735
Total4693304373